Galvin Roy 4
4 · HAEMONETICS CORP · Filed Nov 3, 2022
Insider Transaction Report
Form 4
Galvin Roy
EVP, Chief Commercial Officer
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2022-11-01+5,263→ 5,263 totalExercise: $83.96Exp: 2029-11-01→ Common Stock (5,263 underlying) - Award
Common Stock
2022-11-01+2,382→ 2,382 total
Footnotes (3)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.